Friday, July 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 4 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 12329747

    Use of lipophilic beta-lactam antibiotics and carboxylate esters for the treatment of bacterial infections within citrus and other plant species

    Board of Regents of the Nevada System of Higher Education on behalf of Nevada State College · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  2. US 12329784

    Gut microbiota and treatment of cancer

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  3. US 12332255

    Methods for monitoring treatment of chronic liver disease

    The Regents of the University of Colorado · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  4. US 12329776

    Treatment methods for ALS patients

    The Regents of the University of California · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  5. US 12329739

    Isoflavonoid compounds and methods for the treatment of cancer

    Aardvark Therapeutics, Inc. · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  6. US 12329909

    Airway management systems for pulmonary disorder treatment

    Covidien LP · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  7. US 12329780

    Acute and chronic mitochondrial electron transport chain dysfunction treatments and graphenic materials for use thereof

    The Board of Regents of the University of Texas System · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  8. US 12325705

    Small molecules for the treatment of primary cancer and cancer metastasis

    The Board of Regents of the University of Texas System · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  9. US 12318386

    Combination of XPO1 inhibitors and second agents for the treatment of prostate cancer

    Karyopharm Therapeutics Inc. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  10. US 12318356

    Use of cannabinoids in the treatment of epilepsy

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  11. US 12319929

    Compositions and methods for the treatment of Parkinson's disease

    VOYAGER THERAPEUTICS, INC. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  12. US 12318364

    Isoflavonoid compositions and methods for the treatment of cancer

    Aardvark Therapeutics, Inc. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  13. US 12319744

    Treatment and prevention of hemophilic arthropathy with an antibody against endothelial cell protein C receptor (EPCR)

    The Board of Regents of the University of Texas System · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  14. US 12318375

    Method of treatment with tradipitant

    VANDA PHARMACEUTICALS INC. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  15. US 12318426

    Compositions and methods for the treatment of metabolic and liver disorders

    Viking Therapeutics, Inc. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  16. US 12311054

    Compositions and methods of using propylene sulfide-based polymers for treatment of Chagas disease

    Northwestern University · Granted May 27, 2025 · Expires May 22, 2045

    granted
  17. US 12310986

    Compositions and methods for the treatment of cancer cells by induction of cytotoxic oxidative stress

    The Board of Regents of the University of Texas System · Granted May 27, 2025 · Expires May 22, 2045

    granted
  18. US 12310934

    Methods of treatment of spontaneous preterm birth

    The Regents of the University of California · Granted May 27, 2025 · Expires May 22, 2045

    granted
  19. US 12310929

    Use of rasagiline for the treatment of restless legs syndrome

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 27, 2025 · Expires May 22, 2045

    granted
  20. US 12310965

    Treatment of cancer utilizing an identified adenosine fingerprint

    Arcus Biosciences, Inc. · Granted May 27, 2025 · Expires May 22, 2045

    granted
  21. US 12310992

    Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells

    United Therapeutics Corporation · Granted May 27, 2025 · Expires May 22, 2045

    granted
  22. US 12311017

    Identification of immunologically protective neo-epitopes for the treatment of cancers

    UNIVERSITY OF CONNECTICUT · Granted May 27, 2025 · Expires May 22, 2045

    granted
  23. US 12303724

    Non-adult human dosing of anti-CD30 antibody-drug conjugates for treatment of hematological or lymphoid cancer

    Takeda Pharmaceutical Company Limited · Granted May 20, 2025 · Expires May 15, 2045

    granted
  24. US 12295929

    Intravenous baclofen formulations and treatment methods

    Regents of the University of Minnesota · Granted May 13, 2025 · Expires May 8, 2045

    granted